Back to Authors

Sumbul, Anne

A5044358304 | I4210091812

Mayo Clinic

Bristol-Myers Squibb (United States)

Citations 12

A phase 2 study of a nivolumab (nivo)-containing regimen in patients (pts) with newly diagnosed classical Hodgkin lymphoma (cHL): Study 205 Cohort D.

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: TPS7573-TPS7573

10.1200/jco.2016.34.15_suppl.tps7573

NIVOLUMAB FOR RELAPSED/REFRACTORY CLASSICAL HODGKIN LYMPHOMA AFTER AUTOLOGOUS TRANSPLANT: FULL RESULTS AFTER EXTENDED FOLLOW‐UP OF THE PHASE 2 CHECKMATE 205 TRIAL

Hematological Oncology | June 7, 2017 | Volume: 35 | Issue: S2 | Pages: 135-136

10.1002/hon.2437_124